Work

Abstract OT1-05-02: A phase II clinical trial of the combination of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor positive triple negative breast cancer

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs17-ot1-05-02

Authors: Y Yuan, P Frankel, T Synold, P Lee, S Yost, N Martinez, A Tang, B Mendez, D Schmolze, S Apple, A Hurria, J Waisman, G Somlo, N Tank, M Sedrak, J Mortimer

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2793408804

Cites:

Cited by: 4

Related to: 10